login
login
Image header Agence Europe
Europe Daily Bulletin No. 9426
Contents Publication in full By article 30 / 33
GENERAL NEWS / (eu) eu/eib

EIB and ICO jointly finance Zeltia Group for biopharmaceutical R&D

Luxembourg, 14/05/2007 (Agence Europe) - The European Investment Bank (EIB) and the Instituto de Credito Oficial (ICO) are jointly providing a €50 million facility to Zeltia Group (EIB: €30 million and ICO €20 million) to support the biopharmaceutical research and development activities of its subsidiary company PharmaMar. These R&D activities are aimed at strengthening the company's priority areas, primarily oncology, through products targeting different forms of cancer.

PharmaMar is...

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
WEEKLY SUPPLEMENT